By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Therillia Development Company Inc. 

1010 Sherbrooke Street West
Suite 408
Montreal  Quebec  H3A 2R7  Canada
Phone: 514-564-6474 Fax: 514-564-6424


SEARCH JOBS

Therillia Development Company Inc. is an autonomous portfolio company of Sanderling Ventures located in Montreal. Its mandate is to cost effectively develop novel drug candidates of interest to Sanderling and other venture capital investors from preclinical to clinical proof of concept. Central to this mission is the deployment of scientific platforms to support the proof of concept strategies by identifying potential responder patient populations, rational drug combinations, and the utility of clinical biomarkers. By utilizing an experienced team of drug developers over multiple projects, Therillia will significantly reduce the time and cost of achieving proof of concept data for important new therapeutics. Ultimately, drug candidates successfully developed by Therillia will result in new sustainable biopharmaceutical companies in Quebec.

YEAR FOUNDED:

2014

LEADERSHIP:

CEO: Michael Dixon, C.P.A.


Key Statistics


Email: info@therillia.com
Ownership: Subsidiary

Web Site: Therillia
Employees:
Symbol: 
 



Industry
Biotechnology






Company News
//-->